Autor segons l'article: Revesz, Dora; Ona, Genis; Rossi, Giordano N.; Rocha, Juliana M.; dos Santos, Rafael G.; Hallak, Jaime E. C.; Alcazar-Corcoles, Miguel A.; Bouso, Jose C.;
Departament: Psicologia
Autor/s de la URV: Oña Esteve, Genís
Paraules clau: Validity Symptoms Social support Social status Social distancing Scoring system Safety Religion Psychopathology Psychometry Psychedelic drugs Psychedelic agent Psilocybine Personality Outbreak Midomafetamine Mescaline Mental-health Mental health Male Lysergide Lockdown Lifestyle Language Inventory Human Health-questionnaire ghq-12 Health survey Groups by age Gender Female Drug use Distress syndrome Distress Demography Cross-sectional study Cross-cultural Covid?19 Covid-19 Coronavirus disease 2019 Chinese Behavior Article Aged Adult
Resum: Background: One of the main public health strategies adopted at the beginning of the COVID-19 pandemic consisted of implementing strict lockdowns to stop the transmission of the virus. Despite being an effective measure, the confinement and the associated social isolation create a stressful, potentially lengthy situations that has been proven to have several psychological consequences. Given the potential benefits that certain psychedelic drugs have shown for the treatment of psychological disorders, this study aimed to assess the impact of lifetime psychedelic drug use on mental health in relation to the first strict lockdown adopted by various countries (April-July 2020). Methods: Subjects completed an online survey that inquired about sociodemographic factors, activities, and lifestyle factors during confinement, as well as health and mental health related factors. Subjects were asked about their lifetime use of psychedelic drugs (MDMA, ayahuasca, psilocybin-containing mushrooms, LSD, peyote, San Pedro, Bufo alvarius or 5-MeO-DMT, and others), being classified as regular users (more than once per 6 months), occasional users, or non-users. The survey included psychometric tests used to assess psychological distress, peritraumatic stress, social support, psychopathological symptoms, and personality. Linear regressions were performed with psychedelic drug users as the independent variable and psychometric factors as the outcomes, while correcting for age, gender, language, religion, spirituality, and use of non-psychedelic drugs. Results: The study included 2,974 English, Portuguese, and Spanish speakers (497 regular users of psychedelic drugs, 606 occasional users, and 1,968 non-users). On average, respondents were 36 years old and 70% were female. Psychedelic drug users, especially regular ones, reported less psychological distress, less peritraumatic stress, and more social support. Regarding personality measures, psychedelic drug users scored higher on the novelty-seeking and self-transcendence scales, and lower on cooperativeness. Conclusion: Our findings showed that regular users of psychedelic drugs had less psychological stress and some personality differences when compared to occasional users and non-users. This suggests that either the use of psychedelics might be a protective factor itself or people with certain previous traits are more prone to frequently using psychedelic drugs. Future prospective longitudinal research should investigate the underlying processes observed in this study to develop consistent hypotheses.
Àrees temàtiques: Psychiatry and mental health Psychiatry Psicología Medicina ii Medicina i Interdisciplinar Ensino Engenharias iv Educação física Ciências biológicas ii Ciências biológicas i Ciências ambientais Astronomia / física Administração pública e de empresas, ciências contábeis e turismo
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: genis.ona@urv.cat genis.ona@urv.cat
Data d'alta del registre: 2024-07-27
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.687546/full
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Frontiers In Psychiatry. 12
Referència de l'ítem segons les normes APA: Revesz, Dora; Ona, Genis; Rossi, Giordano N.; Rocha, Juliana M.; dos Santos, Rafael G.; Hallak, Jaime E. C.; Alcazar-Corcoles, Miguel A.; Bouso, Jose (2021). Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study. Frontiers In Psychiatry, 12(), -. DOI: 10.3389/fpsyt.2021.687546
DOI de l'article: 10.3389/fpsyt.2021.687546
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2021
Tipus de publicació: Journal Publications
Repositori URV